Pharmaceutical

The potential of 3D printing in drug development and delivery

3D printing is replacing traditional prototype development approaches across various industries, and use in healthcare is increasing fast.

Jul 26, 2024 - 04:00
The potential of 3D printing in drug development and delivery
3D printing is replacing traditional prototype development approaches across various industries, and use in healthcare is increasing fast.
Read the original article

Tags:

Previous Article

BioAtla receives FDA fast track designation for ozuriftamab vedotin

Next Article

RSV Antibody Passes Final Trials in Win for Merck

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

After decades of neglecting women athletes, sport and exercise medicine is finally catching up

After decades of neglecting women athletes, sport and e...

May 19, 2023

Cullinan advances multiple myeloma drug CLN-619 to a Phase I study

Cullinan advances multiple myeloma drug CLN-619 to a Ph...

Mar 1, 2024

FDA panel says Amgen’s Phase III lung cancer KRAS drug data is unreliable

FDA panel says Amgen’s Phase III lung cancer KRAS drug ...

Oct 7, 2023